Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-CHLORO-3-FORMYLCHROMONE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

42248-31-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 42248-31-7 Structure
  • Basic information

    1. Product Name: 6-CHLORO-3-FORMYLCHROMONE
    2. Synonyms: TIMTEC-BB SBB003463;AKOS BBS-00001401;6-CHLORO-3-FORMYLCHROMONE;6-CHLORO-4-OXO-4 H-1-BENZOPYRAN-3-CARBOXALDEHYDE;6-CHLORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE;IFLAB-BB F2121-0036;6-CHLORO-3-FORMYLCHROMONE 97%;6-Chloro-3-formylchromone,97%
    3. CAS NO:42248-31-7
    4. Molecular Formula: C10H5ClO3
    5. Molecular Weight: 208.6
    6. EINECS: N/A
    7. Product Categories: Chromones
    8. Mol File: 42248-31-7.mol
  • Chemical Properties

    1. Melting Point: 166-168 °C(lit.)
    2. Boiling Point: 351.896 °C at 760 mmHg
    3. Flash Point: 161.508 °C
    4. Appearance: yellow crystalline powder
    5. Density: 1.561 g/cm3
    6. Vapor Pressure: 3.98E-05mmHg at 25°C
    7. Refractive Index: 1.693
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 6-CHLORO-3-FORMYLCHROMONE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 6-CHLORO-3-FORMYLCHROMONE(42248-31-7)
    12. EPA Substance Registry System: 6-CHLORO-3-FORMYLCHROMONE(42248-31-7)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 37/39-26
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 42248-31-7(Hazardous Substances Data)

42248-31-7 Usage

Chemical Properties

yellow crystalline powder

Check Digit Verification of cas no

The CAS Registry Mumber 42248-31-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,2,4 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 42248-31:
(7*4)+(6*2)+(5*2)+(4*4)+(3*8)+(2*3)+(1*1)=97
97 % 10 = 7
So 42248-31-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H5ClO3/c11-7-1-2-9-8(3-7)10(13)6(4-12)5-14-9/h1-5H

42248-31-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-CHLORO-3-FORMYLCHROMONE

1.2 Other means of identification

Product number -
Other names 6-Chloro-3-formylchromone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:42248-31-7 SDS

42248-31-7Relevant articles and documents

Synthesis of Chromeno[2,3-d]pyrimidin-5-one Derivatives from 1,3,5-Triazinanes via Two Different Reaction Pathways

Wang, Taimin,Zhang, Biwei,Hu, Lin,Sun, Haiyan,Wang, Yan,Zhai, Hongbin,Cheng, Bin

, p. 1348 - 1356 (2022/01/27)

1,3,5-Triazinanes, as a kind of versatile building block, are applied in the synthesis of chromeno[2,3-d]pyrimidin-5-one derivatives via two different reaction modes, which perfectly exhibits the powerful function of 1,3,5-triazinane as a three-atom synth

Chromone dioxadiazole compound as well as preparation method and application thereof

-

, (2021/10/30)

The preparation method comprises the following steps: adding an intermediate F and bis (acetoxy) iodobenzene to dichloromethane for reaction to obtain the chromone compound. The invention provides a novel chromone dioxadiazole compound and a preparation method thereof, and overcomes the defects of large toxicity and high preparation cost of the traditional method.

Novel p-functionalized chromen-4-on-3-yl chalcones bearing astonishing boronic acid moiety as MDM2 inhibitor: Synthesis, cytotoxic evaluation and simulation studies

Bhatia, Richa Kaur,Coutinho, Evans C.,Garg, Ruchika,Kancherla, Satyavathi,Kaur, Maninder,Madan, Jitender,Pissurlenkar, Raghuvir R. S.,Singh, Lakhwinder,Yadav, Manmohan

, p. 212 - 228 (2020/03/10)

Background: Novel 4-[3-(6/7/8-Substituted 4-Oxo-4H-chromen-3-yl)acryloyl]phenyl-boronic acid derivatives (5a-h) as well as other 6/7/8-substituted-3-(3-oxo-3-(4-substituted-phenyl)prop-1-enyl)-4H-chromen-4-one derivatives (3a-u) have been designed as p53-MDM2 pathway inhibitors and reported to possess significant cytotoxic properties against several cancer cell lines. Objectives: The current project aims to frame the structure-anticancer activity relationship of chromen-4-on-3-yl chalcones (3a-u/5a-h). In addition, docking studies were performed on these chromeno-chalcones in order to have an insight into their interaction possibilities with MDM2 pro-tein. Methods: Twenty-nine chromen-4-on-3-yl chalcone derivatives (3a-u/5a-h) were prepared by utilizing silica supported-HClO4 (green route with magnificent yield) and tested against four cancer cell lines (HCT116, MCF-7, THP-1, NCIH322). Results: Among the series 3a-u, compound 3b exhibited the highest anticancer activity (with IC50 values ranging from 8.6 to 28.4 μM) overall against tested cancer cell lines. Interestingly, para-Boronic acid derivative (5b) showed selective inhibition against colon cancer cell line, HCT-116 with an IC50 value of 2.35 μM. Besides the emblematic hydrophobic interactions of MDM2 inhibi-tors, derivative 5b was found to exhibit extra hydrogen bonding with GLN59 and GLN72 residues of MDM2 in molecular dynamics (MD) simulation. All the compounds were virtually nontoxic against normal fibroblast cells. Conclusion: Novel compounds were obtained with good anticancer activity especially 6-Chlorochromen-4-one substituted boronic acid derivative 5b. The molecular docking study proposed good activity as a MDM-2 inhibitor suggesting hydrophobic as well as hydrogen bonding interactions with MDM2.

Synthesis and biological evaluation of chromone-3-carboxamides

Gordon, Allen T.,Ramaite, Isaiah D.I.,Mnyakeni-Moleele, Simon S.

, p. 148 - 160 (2021/01/20)

The aim of our study was to synthesize novel chromone-3-carboxamides and to conduct biological evaluations in search for lead compounds for the treatment of a range of debilitating disease states. Corresponding 2-hydroxyacetophenones were subjected to Vilsmeier-Haack formylation to give chromone-3-carbaldehydes, which were subsequently oxidised to give chromone-3-carboxylic acids. Treatment of the carboxylic acids with thionyl chloride resulted in the in situ formation of the corresponding acid chlorides, which were reacted with various amines in the presence of triethylamine to give the corresponding novel chromone-3-carboxamides in good yields. Selected chromone derivatives were then evaluated for their anti-inflammatory, anti-tryponosomal and cytotoxic properties.

NHC-Catalyzed Cascade Reaction between β-Methyl Enals and Dienones for Quick Construction of Complex Multicyclic Lactones

Sun, Jun,Xu, Jun,Nie, Guihua,Jin, Zhichao,Chi, Yonggui Robin

supporting information, p. 2595 - 2599 (2020/03/30)

A NHC-promoted cascade reaction between β-methyl enal and dienone is developed for quick access to multicyclic lactone molecules bearing quaternary chiral carbon centers. Our study constitutes the first 1,6-addition of the acylazolium vinyl enolate γ-carbon via NHC catalysis and provides rapid access to complex lactone molecules that are otherwise difficult to prepare. The structurally sophisticated lactone products bearing up to four fused ring structures are afforded in up to quantitative yields with good to excellent enantioselectivities.

Synthesis, characterization and biological activity of mixed ligands complexes of quinolin-8-ol and substituted chromones with Mn(II), Co(II), Ni(II) and Cu(II) metal ions

Kolhe, Nitin H.,Jadhav, Shridhar S.

, p. 973 - 996 (2018/11/23)

The mixed ligand complexes were synthesized using quinolin-8-ol and substituted chromone derivative with transition metals like Mn(II), Cu(II), Ni(II) and Co(II). These complexes were characterized using elemental analysis by electron dispersive spectroscopy, Fourier transforms infrared, ultraviolet–visible, proton nuclear magnetic resonance, liquid chromatography coupled with mass spectrometry, electron spin resonance spectra, magnetic susceptibility, powder X-ray diffraction, thermogravimetric analysis and scanning electron microscopy. The complexes were screened by biological activities such as antioxidant activity by 2, 2-Diphenyl-1-picrylhydrazyl, antimicrobial activity by the agar well-diffusion method and anticancer activity by yellow tetrazolium (3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide methods. The synthesis of mixed ligand complexes were synthesized by using homoleptic complexes of respective metal complexes of chromones. The FTIR spectra show νM–O the νM–N frequencies are obtained at 515–645?cm?1 and 431–496?cm? 1 respectively. The NMR spectra of Ni(II) complexes were indicating the complexes are paramagnetic in nature. The ESR spectra of copper complexes shows singlet signal, and they indicate that the copper has 2 + oxidation state in complexes. The complexes showed a well-defined crystal system indicated by powder-X-ray diffraction patterns. The thermogram studies show formation of metal oxides residues at the end product of decomposition of complexes. The scanning electron microscope showed complexes were nanocrystalline in nature. The mixed ligand complex of Ni(II) shows 80.73% antioxidant activity as compared to both the ligands and other metal complexes. The antibacterial activity result obtained clearly showed that all complexes were effective against all the microorganisms of Staphylococcus aures, Bacillus subtilis, Escherichia coli and Pseudomonas aeruginos. The inhibition of the cancerous cell is more the case of Ni (II) complexes as compared with other complexes.

One pot and metal-free approach to 3-(2-Hydroxybenzoyl)-1-aza-anthraquinones

Yuan, Jiaqi,He, Qian,Song, Shanshan,Zhang, Xiaofei,Miao, Zehong,Yang, Chunhao

supporting information, (2019/08/30)

Herein, a direct strategy to synthesize 3-(2-hydroxybenzoyl)-1-aza-anthraquinones with excellent efficiency,mild conditions, and benign functional group compatibilitywas reported. Avariety of 3-formylchromone compounds were employed as compatible substrates and this protocol gave the 3-(2-hydroxybenzoyl)-1-aza-anthraquinone derivatives in good to excellent yields without inert gas and expensive transition metal catalysts. Some compounds displayed good anti-proliferative activities.

Synthesis and Antimicrobial Activity of (Z)-3-{[3-Oxobenzofuran-2(3H)-ylidene]methyl}-4H-chromen-4-one Derivatives

Pervaram,Ashok,Reddy,Sarasija,Rao

, p. 566 - 572 (2018/04/23)

A series of (Z)-3-{[3-oxobenzofuran-2(3H)-ylidene]methyl}-4H-chromen-4-one derivatives have been synthesized from 2-hydroxyl acetophenones by the Vilesmeier–Haack reaction, Claisen–Schmidt reaction and mercury(II) acetate/cupric bromide. All the synthesized compounds were characterized by IR, 1H and 13C NMR, and mass spectral data and elemental analysis. The products were tested for their in vitro antimicrobial activity.

Hydrazide derivatives and anticancer agent comprising the same

-

Paragraph 0148-0150, (2019/02/20)

The present invention relates to novel hydrazide derivatives, pharmaceutically-acceptable salt of the same, a pharmaceutical composition including the hydrazide derivatives for prevention and treatment of cancer, and a dietary supplement composition inclu

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 42248-31-7